Trestle Biotherapeutics Analysis: $0.1M Raised

What is Trestle Biotherapeutics?

Trestle Biotherapeutics develops implantable therapeutic tissues for patients with end-stage renal disease. Their focus is on creating stem cell-based solutions to reduce reliance on dialysis and delay the need for kidney transplants. The company aims to leverage advancements in stem cell biology and biofabrication to address kidney disease.

Product Features & Capabilities

• Implantable bioengineered tissues for kidney disease
• Stem cell-based therapeutic solutions
• Research collaborations in regenerative medicine

How much Trestle Biotherapeutics raised